Lipodystrophies E88.10

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 11.06.2022

Dieser Artikel auf Deutsch

Synonym(s)

Lipatrophy; Lipoatrophy; Lipodystrophies; Lipodystrophies Syndromes; Lipodystrophy; Lipodystrophy Syndromes; Lipoystrophies

Definition
This section has been translated automatically.

Very differently used and therefore not clearly defined term for a localized or generalized, congenital or acquired, partial or complete loss of (subcutaneous) fatty tissue.

The term lipodystrophy is often used synonymously with lipoatrophy.

However, lipodystrophy includes lipatrophy.

Lipodystrophy can be accompanied by a simultaneous redistribution of fatty tissue (e.g. HIV-induced lipodystrophy).

Classification
This section has been translated automatically.

A classification of lipodystrophies according to their mode of origin (acquired or congenital/familial), their pattern of affection (localized, partial, or generalized), and the presence of endocrinologic (diabetes mellitus) and other internal disorders (hepatomegaly, glomerulonephritis, hypertriglyceridemia) is accepted.

Literature
This section has been translated automatically.

  1. Akdeniz S et al (2000) Partial lipodystrophy with hemithoracic atrophy. Br J Dermatol 143: 665-666
  2. Behrens GM et al (2003) Clinical impact of HIV-related lipodystrophy and metabolic abnormalities on cardiovascular disease. AIDS 17: S149-154
  3. Buyukgebiz A et al (1999) Localized lipatrophia due to recombinant growth hormone therapy in a child with 6.7 kilo base gene deletion isolated growth hormone deficiency. J Pediatr Endocrinol Metabol 12: 85-87
  4. Carr A (2003) HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS 17: 141-148
  5. Carr A et al (2003) An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 361: 726-735
  6. Hartmann M et al (2000) Lipodystrophy syndrome in HIV infection. dermatologist 51: 159-163
  7. Helmet TN et al (2001) Lipodystrophy. Cutis 67: 163-164
  8. Joffe BI et al (2001) From lipodystrophy syndromes to diabetes mellitus. Lancet 357: 1379-1381
  9. Martinez E et al (2003) Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection. N Engl J Med 349: 1036-1046
  10. Sattler F (2003) Body habitus changes related to lipodystrophy. Clin Infect Dis 36: S84-S90

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 11.06.2022